The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

BACKGROUND: Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Part Fibre Toxicol
Main Authors: Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773151/
https://ncbi.nlm.nih.gov/pubmed/29343276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12989-018-0241-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados